Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 11 of 11 publications.

Hollis K, Gilsenan A. Design and implementation of surveys to assess patient and health care provider understanding of risks and safe use conditions. In: Andrews EB, Moore M, editors. Mann's pharmacovigilance. 3rd ed. Hoboken: NJ. John Wiley & Sons; 2014.

Cole JA, Elbert A, Haas J, Hewitt K, Bertagna Leavy M, Marshall BC, Rothman KJ, Tarver M. Modifying and Stopping Registries. In: Gliklich RE, Dreyer NA, Leavy MB, editors. Registries for evaluating patient outcomes: a user's guide. 3rd edition ed. Rockville: MD. Agency for Healthcare Research and Quality; 2014.

Smith VK, Mansfield C, Strong A. How should the health benefits of food safety programs be measured? In: Bolin K, Blomquist GC, editors. Advances in health economics and health services research. Somerville: MA. Emerald Group Publishing Limited; 2014. p.161-202.

Brown DS, Poulos C, Johnson FR, Chamiec-Case L, Messonnier ML. Adolescent girls' preferences for HPV vaccines: A discrete choice experiment. In: Glenn C. Blomquist, Kristian Bolin (ed.), editors. Preference measurement in health. Bingley: United Kingdom. Emerald Group Publishing Limited; 2014. p.93-121. doi: 10.1108/S0731-2199_2014_0000024002

Mauskopf J.Anthony J. Culyer (ed.),, editors. Budget-impact analysis. San Diego: United States. Elsevier; 2014. p.98-107.

Mauskopf J. Budget-impact analysis. In: Culyer AJ, editors. Encyclopedia of health economics, Vol 1. San Diego. Elsevier; 2014. p.98-107.

Johnson M, Gildea (Millar) L. Audit and supervision. In: Daniel Sauca, editors. First do no harm - recommendations for the prevention of healthcare associated infections. Zalău: Romania. Caiete Silvane Publishing House; 2013. p.237-49.

Johnson M, Millar L. Primum non nocere în primul rând sâ nu faci râu; recomandări de prevenire a infecţiilor asociate îngrijirilor medicale. In: Daniel Săuca, editors. Caiete silvane. Zalău: Romania. Carole Hallam & Ramona Marincaş; 2013. p.237-49.

Gilsenan AW, Andrews EB. Considerations and strategies for benefit-risk assessment in the real-world setting. In: Sashegyi A, Felli J, Noel R, editors. Benefit-risk assessment in pharmaceutical research and development. 1st ed. Boca Raton: United States. CRC Press; 2013. p.153-64.

Hawe E, Cockcroft L. The OHE guide to UK health and health care statistics. 2nd ed. London: United Kingdom. OHE Research; 2013.

Rothman KJ. Interpretation of epidemiologic studies on smokeless tobacco and cancer. In: Health implications of smokeless tobacco. Bethesda: MD. NIH Consensus Development Conference; 1986.